Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D02JZS
|
||||
Former ID |
DNC003173
|
||||
Drug Name |
4-(Acetylamino)-3-Guanidinobenzoic Acid
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [1] | ||
Structure |
![]() |
Download2D MOL |
|||
Formula |
C10H12N4O3
|
||||
Canonical SMILES |
CC(=O)NC1=C(C=C(C=C1)C(=O)O)N=C(N)N
|
||||
InChI |
1S/C10H12N4O3/c1-5(15)13-7-3-2-6(9(16)17)4-8(7)14-10(11)12/h2-4H,1H3,(H,13,15)(H,16,17)(H4,11,12,14)
|
||||
InChIKey |
UDQJOWCVSMIZJP-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Neuraminidase | Target Info | Inhibitor | [1] | |
KEGG Pathway | Other glycan degradation | ||||
References | |||||
REF 1 | DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Nucleic Acids Res. 2011 Jan;39(Database issue):D1035-4. Nucleic Acids Res. 2011 January | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.